In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save ...

Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s ...

India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...

India's biotechnology sector has surged from $35.5 billion in 2014 to $165.7 billion in 2024, aiming for $300 billion by 2030 ...

Indian pharmaceutical and biotech sectors are witnessing benefits from the global shift away from China. Companies report increasing conversions of enquiries into contracts. While significant ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners, by more than ...

The PRIP scheme aims to boost India's pharmaceutical R&D by facilitating applications for innovative med tech.

India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...

Indian pharmaceutical and biotech sectors have started witnessing tangible benefits from the global shift away from China, as early signs of the China 1 strategy materialising emerge, according to a ...

Novo Nordisk launches Wegovy® in India, a weight management therapy reducing cardiovascular risks for people with obesity.